argenx SE (ARGX)
NASDAQ: ARGX · Real-Time Price · USD
551.72
+0.50 (0.09%)
Jul 1, 2025, 1:23 PM - Market open
argenx SE Market Cap
argenx SE has a market cap or net worth of $33.69 billion as of July 1, 2025. Its market cap has increased by 48.79% in one year.
Market Cap
33.69B
Enterprise Value
30.06B
1-Year Change
48.79%
Ranking
Category
Stock Price
$551.72
Market Cap Chart
Since May 18, 2017, argenx SE's market cap has increased from $618.00M to $33.69B, an increase of 5,351.22%. That is a compound annual growth rate of 63.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2025 | 33.49B | -8.92% |
| Dec 31, 2024 | 36.77B | 72.75% |
| Dec 29, 2023 | 21.29B | 2.05% |
| Dec 30, 2022 | 20.86B | 15.89% |
| Dec 31, 2021 | 18.00B | 29.92% |
| Dec 31, 2020 | 13.85B | 126.49% |
| Dec 31, 2019 | 6.12B | 96.21% |
| Dec 31, 2018 | 3.12B | 83.75% |
| Dec 29, 2017 | 1.70B | 174.53% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 699.81B |
| Johnson & Johnson | 367.53B |
| AbbVie | 327.88B |
| Novo Nordisk | 307.21B |
| UnitedHealth Group | 283.00B |
| Novartis AG | 236.92B |
| Abbott Laboratories | 236.64B |
| AstraZeneca | 215.00B |